Welcome to European Tribune. It's gone a bit quiet around here these days, but it's still going.
Display:
Counter Currents | USA Must Avoid Misuse of Its 'Exorbitant Privilege' of Dollar Domination, 4 Mar
...The special position of dollar as reserve currency confers certain very important trade, financial and political advantages to the USA. In a widely discussed paper titled `An Existential Threat to the US Dollar' the authors Daniel Tenengauzer, John Vellis and Geoff Yu ( BNY-MECCON--Aerial View Magazine, September 2020) say, " The status of the USD allows the US, as its issuer, to run huge international deficits in its own currency, and has allowed international liabilities to be paid off at a lower rate of interest than the US receives in income from abroad." Clearly it is a huge advantage to clear international payments in its own currency. As such the USA authorities would like this arrangement to continue for as long as possible.

However this excessive power should not be used in arbitrary ways and to inflict undue and high costs on others, as in the case of imposing sweeping sanctions. In the case if Iraq, which had been earlier devastated by an invasion led by the USA, these sanctions are reported to have led to around half a million deaths. This was followed by a second invasion as well. ...

archived "They [mRNA] will represent 60% or 70% of the market. The other guys will die"
by Cat on Fri Mar 4th, 2022 at 06:07:22 AM EST
[ Parent ]
Things you should know about the new Pfizer documents

Pfizer claimed repeatedly in their documents to the FDA that their vaccine would "prevent" COVID-19.

Pfizer knew the injection's adverse effects would increase with more injections of continuing boosters.

Pfizer knew their injections did not stay at the injection site.

Pfizer knew that the vaccinated group reported far more systemic adverse events than the placebo group.

Pfizer knew that the efficacy of the vaccine waned very quickly over time; by as much as 50% in as little as 1 month after the second dose. How come we weren't warned about that???

Pfizer defended VAERS (because they didn't want extra reporting cost burdens).

There are six individuals that signed up for two different clinical trials at two different sites which is really odd.

Pfizer knew vaccinated individuals could still catch COVID-19 and test positive.

There are 1,448 pages comprising 9,704 individual subjects who were excluded from the trials. There isn't enough detail to know why.

Pfizer paid $2,875,842.00 for their application to the FDA. This is more of a point of information for now.

It is troubling that Pfizer redacts information that is not proprietary that would be very helpful in assessing the data such as the number of doses administered in the ADVERSE EVENTS OF SPECIAL INTEREST" (AESI) document (aka the 5.3.6 document).

Pfizer only tests you for COVID if you have at least one symptom. If the vaccine suppresses symptoms (which it apparently does), then it will falsely appear as if the vaccine reduces the number of COVID cases.

How could anaphylaxis not show up in the Phase 3 trial on any of the 44,000 patients, yet show up as a major safety concern in the post-marketing document?!?

~~

Kirsch understands statistics and probabilities, and questions in his article, how could anaphylaxis be completely missing from the Pfizer Phase 3 report, when it's identified as an "important identified risk" in the rest of the report? Not one instance reported, and this defies all logic. As he says:
Anaphylaxis not seen in the trial at all; only seen post-marketing. That's impossible.
So the books are cooked. And this is why Pfizer sued (and lost) to be given 75 years to release these reports. And this is what was presented to FDA for emergency approval. And countless people are still digging through it to make sense of it, yet FDA parsed it all and gave the authorization in record time.

by Tom2 on Fri Mar 11th, 2022 at 11:00:47 AM EST
[ Parent ]
I noted last week that FDA released the first (court ordered) 55K page tranche of Pfizer docs to plaintiff, phmpt.org. Predictably, the "war effort" here and over there--orchestrated by the Biden admin, US Congress, and MSM agitprop--has buried this victory for FOIA. Which is discovery, pure and simple prerequisite fact finding in both legal and scientific domains of "truth".

As far as I can tell, information gleaned by marginal correspondents (blogs, vlogs, trade rags) as yet is limited to a small set of material for publicity and strategic purposes of principal adversaries and their "stakeholders". Predictably, again, agents deeply invested in professional sinecure* and federal subsidy of pharma industry R&D immediately mounted a PR campaigns to undermine latent skepticism of public health apparatus to FIGHT COVID, but the intelligence of their own peers who successfully litigated FDA's embargo. Below, an unscientific survey of knowledge and crisis management tactics forthcoming--

Endpoints News, FDA begins court-mandated release of thousands of pages on Pfizer's Covid-19 vaccine review, 2 Mar
- select phmpt documentary evidence

FDA News, FDA Starts Releasing Thousands of Pfizer COVID-19 Vaccine Documents, 4 Mar
- $1,695.00 subscription only

MedPage Today, Court-ordered release runs risk of "cherry picking and taking things out of context", 7 Mar
- PhD, JD, a "regulatory strategy" imprimature

SEARCH TERM phmpt
archived "grave danger" moot court

* cf. Zigmunt Bauman's topical literature

by Cat on Fri Mar 11th, 2022 at 03:15:43 PM EST
[ Parent ]
9 Mar

"single-spaced" < wipes tears > I'll resist the temptation to post yet again Congressional Research Service (CRS) rolling, "single-spaced" compilation, "Instances of Use of United States Armed Forces Abroad, 1798-2022"

by Cat on Fri Mar 11th, 2022 at 03:27:26 PM EST
[ Parent ]
9 Mar

Now, pardon me, while I wait < checks watch > hmm 36 months for this torious drama to conclude in US courts PLUS another hmmm 4 years before disbursement of class action settlement.

by Cat on Fri Mar 11th, 2022 at 05:04:53 PM EST
[ Parent ]

Display:

Top Diaries

Occasional Series